BACKGROUND: Onchocerciasis can be effectively controlled by annual mass treatment with ivermectin in endemic communities. However, in communities that are endemic for loiasis there may be significant risk of severe adverse reactions after ivermectin treatment. Planning of control requires therefore mapping of these two infections using rapid assessment tools developed for each disease. These tools were initially implemented independently till the feasibility of combining them was demonstrated. This paper reports the results of integrated mapping in four epidemiological zones in the Democratic Republic of Congo and its implications on operational decision-making on ivermectin treatment. METHODS: Rapid assessment surveys were conducted between 2004 and 2005 using both rapid epidemiological mapping of onchocerciasis (REMO) and rapid assessment procedure for loiasis (RAPLOA). The survey results were subjected to a spatial analysis in order to generate for each of the two diseases maps of the estimated prevalence of infection throughout the four zones. RESULTS: Surveys were undertaken in 788 villages where 25,754 males were examined for palpable onchocercal nodules and 62,407 people were interviewed for history of eye worm. The results showed major differences in the geographic distribution of the two diseases. Loiasis was highly endemic in some areas, where special precautions were required, but not in others where routine ivermectin treatment could proceed. CONCLUSION: Integrated rapid mapping of onchocerciasis and loiasis reduces both time and cost of surveys and greatly facilitates operational decision-making on ivermectin treatment in areas where loiasis might be co-endemic.
BACKGROUND:Onchocerciasis can be effectively controlled by annual mass treatment with ivermectin in endemic communities. However, in communities that are endemic for loiasis there may be significant risk of severe adverse reactions after ivermectin treatment. Planning of control requires therefore mapping of these two infections using rapid assessment tools developed for each disease. These tools were initially implemented independently till the feasibility of combining them was demonstrated. This paper reports the results of integrated mapping in four epidemiological zones in the Democratic Republic of Congo and its implications on operational decision-making on ivermectin treatment. METHODS: Rapid assessment surveys were conducted between 2004 and 2005 using both rapid epidemiological mapping of onchocerciasis (REMO) and rapid assessment procedure for loiasis (RAPLOA). The survey results were subjected to a spatial analysis in order to generate for each of the two diseases maps of the estimated prevalence of infection throughout the four zones. RESULTS: Surveys were undertaken in 788 villages where 25,754 males were examined for palpable onchocercal nodules and 62,407 people were interviewed for history of eye worm. The results showed major differences in the geographic distribution of the two diseases. Loiasis was highly endemic in some areas, where special precautions were required, but not in others where routine ivermectin treatment could proceed. CONCLUSION: Integrated rapid mapping of onchocerciasis and loiasis reduces both time and cost of surveys and greatly facilitates operational decision-making on ivermectin treatment in areas where loiasis might be co-endemic.
Authors: Honorat Gustave Marie Zouré; Samuel Wanji; Mounkaïla Noma; Uche Veronica Amazigo; Peter J Diggle; Afework Hailemariam Tekle; Jan H F Remme Journal: PLoS Negl Trop Dis Date: 2011-06-28
Authors: Samuel Wanji; Dowo O Akotshi; Maurice N Mutro; Floribert Tepage; Tony O Ukety; Peter J Diggle; Jan H Remme Journal: Parasit Vectors Date: 2012-02-02 Impact factor: 3.876
Authors: Emmanuel Emukah; Lindsay J Rakers; Barminas Kahansim; Emmanuel S Miri; Bertram E B Nwoke; Emily Griswold; Yisa Saka; Ifeoma Anagbogu; Emmanuel Davies; Cephas Ityonzughul; Michael D'Ambrosio; Matthew Bakalar; Daniel A Fletcher; Thomas Nutman; Joseph Kamgno; Frank O Richards Journal: Am J Trop Med Hyg Date: 2018-05-10 Impact factor: 3.707
Authors: Didier K Bakajika; Maurice M Nigo; Jean Pierre Lotsima; Germain A Masikini; Kerstin Fischer; Melanie M Lloyd; Gary J Weil; Peter U Fischer Journal: Am J Trop Med Hyg Date: 2014-09-15 Impact factor: 2.345
Authors: Louise A Kelly-Hope; Jorge Cano; Michelle C Stanton; Moses J Bockarie; David H Molyneux Journal: Parasit Vectors Date: 2014-07-03 Impact factor: 3.876
Authors: Mounkaila Noma; Honorat G M Zouré; Afework H Tekle; Peter A I Enyong; Bertram E B Nwoke; Jan H F Remme Journal: Parasit Vectors Date: 2014-07-22 Impact factor: 3.876